North American Pit Viper venom toxins

North American Pit Viper venom toxins refer to the complex mixture of proteins and enzymes secreted by snakes of the Crotalinae subfamily, which includes rattlesnakes (Crotalus and Sistrurus), copperheads, and cottonmouths (Agkistrodon) [3, 11]. These toxins primarily consist of snake venom metalloproteinases (SVMPs), serine proteases (SVSPs), and phospholipases A2 (PLA2), which work synergistically to immobilize prey and initiate digestion [6, 9]. In humans, envenomation by these toxins leads to a range of clinical manifestations, most notably local tissue necrosis, systemic hemotoxicity (such as thrombocytopenia and hypofibrinogenemia), and occasionally neurotoxicity [3, 17]. The pharmacological target in medical management is the neutralization of these toxic components to prevent progressive injury [12, 14]. Therapeutic intervention involves the administration of antivenoms, such as Crotalidae Polyvalent Immune Fab (ovine) or Crotalidae Immune F(ab')2 (equine), which contain purified antibody fragments that bind specifically to the venom antigens [5, 13]. This binding prevents the toxins from interacting with physiological targets like clotting factors and cell membranes, facilitating their clearance from the bloodstream [8, 10]. Monitoring of efficacy typically involves tracking hematologic biomarkers like platelet counts and fibrinogen levels alongside the clinical assessment of swelling and systemic symptoms [3, 14].

Other names

Crotalidae venom toxinsCrotalid venomRattlesnake venomCopperhead venomCottonmouth venomPit viper zootoxins

Passive immunization through the binding of specific antibody fragments (Fab or F(ab')2) to circulating venom antigens, which neutralizes their enzymatic and toxic activities and prevents interaction with host receptors or substrates [5, 8, 10].